During tumor development, myriad oncogenic pathways such as DVL3/Wnt/β-catenin, AKT/ERK/FOXM1, and mTOR/p70S6K signals etc. are constitutively activated in cancer cells. This evidence concerns the gene RPS6KB1 and neoplasm.